Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

60%

3 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
2(50.0%)
Phase 4
1(25.0%)
Phase 1
1(25.0%)
4Total
Phase 3(2)
Phase 4(1)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07031999Phase 1Not Yet Recruiting

Use of Biocompatible Thermoplastic Impregnated With Vancomycin as a Temporary Orthopedic Spacer

Role: lead

NCT07001527Phase 3Completed

Dressing Impregnated With Chlorhexidine and Vancomycin for the Prophylaxis of Central Venous Catheter-related Infections - a Randomized Trial

Role: lead

NCT06107569Phase 3Not Yet Recruiting

Treatment of CDI and Recurrence With Fecal Microbiota Transplant Using Promicrobioma

Role: lead

NCT02527928Unknown

Cost-Effectiveness of Amphotericin B

Role: lead

NCT01626560Phase 4Completed

The Effects of Daptomycin and Cytokines Production in Comparison With Vancomycin

Role: lead

All 5 trials loaded